IN2013MU01927A - - Google Patents

Download PDF

Info

Publication number
IN2013MU01927A
IN2013MU01927A IN1927MU2013A IN2013MU01927A IN 2013MU01927 A IN2013MU01927 A IN 2013MU01927A IN 1927MU2013 A IN1927MU2013 A IN 1927MU2013A IN 2013MU01927 A IN2013MU01927 A IN 2013MU01927A
Authority
IN
India
Prior art keywords
azilsartan medoxomil
preparation
present
improved process
azilsartan
Prior art date
Application number
Other languages
English (en)
Inventor
Shriprakash Dhar Dwivedi
Kumar Kamlesh Singh
Jitendra Maganbhai Gajera
Jayeshkumar Mohanlal PANDYA
Original Assignee
Cadila Healthcare Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cadila Healthcare Ltd filed Critical Cadila Healthcare Ltd
Priority to IN1927MU2013 priority Critical patent/IN2013MU01927A/en
Publication of IN2013MU01927A publication Critical patent/IN2013MU01927A/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN1927MU2013 2013-06-01 2013-06-01 IN2013MU01927A (ru)

Priority Applications (1)

Application Number Priority Date Filing Date Title
IN1927MU2013 IN2013MU01927A (ru) 2013-06-01 2013-06-01

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IN1927MU2013 IN2013MU01927A (ru) 2013-06-01 2013-06-01

Publications (1)

Publication Number Publication Date
IN2013MU01927A true IN2013MU01927A (ru) 2015-05-29

Family

ID=54394964

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1927MU2013 IN2013MU01927A (ru) 2013-06-01 2013-06-01

Country Status (1)

Country Link
IN (1) IN2013MU01927A (ru)

Similar Documents

Publication Publication Date Title
MX2016002571A (es) Regulador de ph de transduccion.
AU2015207757A8 (en) N-azaspirocycloalkane substituted n-heteroaryl compounds and compositions for inhibiting the activity of SHP2
MX365294B (es) Inhibidores de proteína cinasa dependiente de adn.
PH12014502010A1 (en) Bispecific antibodies against human tweak and human il17 and uses thereof
MX2016016143A (es) Compuestos de [1,2,4]triazol sustituido.
MY193728A (en) Muscarinic receptor agonists
MX2020001756A (es) Compuestos deuterados del inhibidor vmat y el uso de dichos compuestos.
MX2016004556A (es) Composicion de hueso comprimido y metodo para usar la misma.
IN2012MU03723A (ru)
MX345926B (es) Nuevas composiciones, producción de las mismas y uso de las mismas para la producción de poliamidas coladas.
MX2016006975A (es) Compuestos, composicion farmaceutica y metodos para su uso en el tratamiento de enfermedades inflamatorias.
IN2013MU03641A (ru)
MY180844A (en) Solid pharmaceutical compositions comprising biopterin derivatives and uses of such compositions
MX2014010433A (es) Nueva forma cristalina de sulfato de sitagliptina.
PH12015502747A1 (en) Novel compounds for the treatment of cancer
PH12016500495A1 (en) Compositions for the treatment of hypertension and/or fibrosis
MX2015000179A (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
MX2015016603A (es) Composiciones de corticosteroides.
MX2015016410A (es) Esteres de acidos oligo-hidroxicarboxilicos y uso de los mismos.
IN2015DN02109A (ru)
MX2015012523A (es) Metodos para elaborar composiciones antineoplasicas.
SG10201803880TA (en) Stable compositions of neuroactive peptides
IN2013MU01927A (ru)
PH12017501147A1 (en) Total synthesis of trioxacarcin dc-45-a2 and preparation of trioxacarcin analogs
MX2015008947A (es) Nuevas composiciones antifungicas.